Barbara Pistilli

Also affiliated with Université Paris-Saclay, Institut Gustave Roussy

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial”.

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Annals of Oncology(2020)10.1016/j.annonc.2020.05.012

N/A

3.1DataRank · unranked

106 citations

Sara A. Hurvitz, Jack A. Di Palma, Ron Bose, A. Jo Chien, Nicholas Iannotti +48 more

Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study

ESMO Open(2022)10.1016/j.esmoop.2022.100571

N/A

0.427DataRank · unranked

11 citations

Barbara Pistilli, Irene Braña, Geoffrey I. Shapiro, José Trigo, Víctor Moreno +13 more